Product NDC: | 52959-965 |
Proprietary Name: | ALPRAZOLAM |
Non Proprietary Name: | ALPRAZOLAM |
Active Ingredient(s): | 1 mg/1 & nbsp; ALPRAZOLAM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52959-965 |
Labeler Name: | H.J. Harkins Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077996 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070328 |
Package NDC: | 52959-965-15 |
Package Description: | 15 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52959-965-15) |
NDC Code | 52959-965-15 |
Proprietary Name | ALPRAZOLAM |
Package Description | 15 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52959-965-15) |
Product NDC | 52959-965 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ALPRAZOLAM |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20070328 |
Marketing Category Name | ANDA |
Labeler Name | H.J. Harkins Company, Inc. |
Substance Name | ALPRAZOLAM |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |